Literature DB >> 32757874

Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder.

Pınar Aydoğan Avşar1, Ümit Işık1, Evrim Aktepe1, Faruk Kılıç2, Duygu Kumbul Doğuç3, Halil İbrahim Büyükbayram3.   

Abstract

OBJECTIVE: This study aimed to investigate serum zonulin and claudin-5 levels of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and healthy controls by controlling the parameters such as age, sex and body mass index (BMI) percentile which are known to affect these parameters.
METHOD: A total of 80 treatment-naive children and adolescents with ADHD and 40 healthy volunteer controls aged 8-12 years were enrolled in this study. The severities of ADHD symptoms were assessed via parent- and teacher-rated questionnaires. The severity of anxiety and depression symptoms of the children were assessed by the self-report inventories. Serum levels of zonulin and claudin-5 were measured using commercial enzyme-linked immunosorbent assay kits.
RESULTS: The multivariate analysis of covariance (MANCOVA) revealed a significant main effect of groups in the serum zonulin and claudin-5 levels, an effect that was independent of age, sex and BMI percentile. Significant differences were found between the study groups in terms of serum log-claudin-5 levels. However, there was no significant difference between the study groups in terms of serum zonulin levels.
CONCLUSION: These findings provide additional evidence for dysregulation of the blood-brain barrier, especially abnormalities in claudin-5 function, which may be involved in the aetiology of ADHD.Key pointsADHD is one of the most common neurodevelopmental disorders of childhood. Although ADHD is quite common, its aetiology has yet to be fully explained.In recent years, studies on the relationship between intestinal and blood-brain brain barrier permeability and psychiatric disorders have increased.In our study, serum claudin-5 levels were higher in the ADHD group compared to the control group, while serum zonulin levels did not differ between the groups.

Entities:  

Keywords:  Attention-deficit/hyperactivity disorder; blood–brain barrier; claudin-5; intestinal permeability; zonulin

Mesh:

Substances:

Year:  2020        PMID: 32757874     DOI: 10.1080/13651501.2020.1801754

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  5 in total

1.  Investigation of the Relation between Epithelial Barrier Function and Autism Symptom Severity in Children with Autism Spectrum Disorder.

Authors:  Kevser Nalbant; Semih Erden; Abdullah Yazar; İbrahim Kılınç
Journal:  J Mol Neurosci       Date:  2022-01-06       Impact factor: 3.444

2.  Advances in brain barriers and brain fluids research in 2021: great progress in a time of adversity.

Authors:  Richard F Keep; Hazel C Jones; Lester R Drewes
Journal:  Fluids Barriers CNS       Date:  2022-06-09

Review 3.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

4.  Zonulin and claudin-5 levels in multisystem inflammatory syndrome and SARS-CoV-2 infection in children.

Authors:  Ahmet O Kılıç; Fatih Akın; Abdullah Yazar; Özge Metin Akcan; Cemile Topcu; Orkun Aydın
Journal:  J Paediatr Child Health       Date:  2022-05-30       Impact factor: 1.929

5.  Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: a prospective case-control study.

Authors:  Dragos Ciocan; Anne-Marie Cassard; Laurent Becquemont; Céline Verstuyft; Cosmin Sebastian Voican; Khalil El Asmar; Romain Colle; Denis David; Séverine Trabado; Bruno Feve; Philippe Chanson; Gabriel Perlemuter; Emmanuelle Corruble
Journal:  J Psychiatry Neurosci       Date:  2021-05-19       Impact factor: 6.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.